img

Global Immune Cell Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Immune Cell Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Immune Cell Therapy is a medical treatment approach that involves modifying a patient's own immune cells, typically T cells, to enhance their ability to recognize and attack cancer cells or other diseases.
Immune Cell Therapy report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Immune Cell Therapy market is projected to reach US$ 15060 million in 2033, increasing from US$ 3435 million in 2023, with the CAGR of 23.7% during the period of 2023 to 2033. Demand from Stomach Cancer and Lung Cancer are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2023, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2023. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2023. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immune Cell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Segment by Type
T Cell Therapy
Natural Killer (NK) Cell Therapy
Other

Segment by Application


Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immune Cell Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Immune Cell Therapy introduction, etc. Immune Cell Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Immune Cell Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.

Table of Content

1 Market Overview of Immune Cell Therapy
1.1 Immune Cell Therapy Market Overview
1.1.1 Immune Cell Therapy Product Scope
1.1.2 Immune Cell Therapy Market Status and Outlook
1.2 Global Immune Cell Therapy Market Size Overview by Region 2018 VS 2023 VS 2033
1.3 Global Immune Cell Therapy Market Size by Region (2018-2033)
1.4 Global Immune Cell Therapy Historic Market Size by Region (2018-2023)
1.5 Global Immune Cell Therapy Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Immune Cell Therapy Market Size (2018-2033)
1.6.1 North America Immune Cell Therapy Market Size (2018-2033)
1.6.2 Europe Immune Cell Therapy Market Size (2018-2033)
1.6.3 Asia-Pacific Immune Cell Therapy Market Size (2018-2033)
1.6.4 Latin America Immune Cell Therapy Market Size (2018-2033)
1.6.5 Middle East & Africa Immune Cell Therapy Market Size (2018-2033)
2 Immune Cell Therapy Market by Type
2.1 Introduction
2.1.1 T Cell Therapy
2.1.2 Natural Killer (NK) Cell Therapy
2.1.3 Other
2.2 Global Immune Cell Therapy Market Size by Type: 2018 VS 2023 VS 2033
2.2.1 Global Immune Cell Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Immune Cell Therapy Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Immune Cell Therapy Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Immune Cell Therapy Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Immune Cell Therapy Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Immune Cell Therapy Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Immune Cell Therapy Revenue Breakdown by Type (2018-2033)
3 Immune Cell Therapy Market Overview by Application
3.1 Introduction
3.1.1 Stomach Cancer
3.1.2 Lung Cancer
3.1.3 Colorectal Cancer
3.1.4 Esophageal Cancer
3.1.5 Pancreatic Cancer
3.1.6 Other
3.2 Global Immune Cell Therapy Market Size by Application: 2018 VS 2023 VS 2033
3.2.1 Global Immune Cell Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Immune Cell Therapy Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Immune Cell Therapy Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Immune Cell Therapy Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Immune Cell Therapy Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Immune Cell Therapy Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Immune Cell Therapy Revenue Breakdown by Application (2018-2033)
4 Immune Cell Therapy Competition Analysis by Players
4.1 Global Immune Cell Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Cell Therapy as of 2023)
4.3 Date of Key Players Enter into Immune Cell Therapy Market
4.4 Global Top Players Immune Cell Therapy Headquarters and Area Served
4.5 Key Players Immune Cell Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Immune Cell Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Adaptimmune
5.1.1 Adaptimmune Profile
5.1.2 Adaptimmune Main Business
5.1.3 Adaptimmune Immune Cell Therapy Products, Services and Solutions
5.1.4 Adaptimmune Immune Cell Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Adaptimmune Recent Developments
5.2 Altor Bioscience Corporation
5.2.1 Altor Bioscience Corporation Profile
5.2.2 Altor Bioscience Corporation Main Business
5.2.3 Altor Bioscience Corporation Immune Cell Therapy Products, Services and Solutions
5.2.4 Altor Bioscience Corporation Immune Cell Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Altor Bioscience Corporation Recent Developments
5.3 Cellectis
5.3.1 Cellectis Profile
5.3.2 Cellectis Main Business
5.3.3 Cellectis Immune Cell Therapy Products, Services and Solutions
5.3.4 Cellectis Immune Cell Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Juno Therapeutics Recent Developments
5.4 Juno Therapeutics
5.4.1 Juno Therapeutics Profile
5.4.2 Juno Therapeutics Main Business
5.4.3 Juno Therapeutics Immune Cell Therapy Products, Services and Solutions
5.4.4 Juno Therapeutics Immune Cell Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Juno Therapeutics Recent Developments
5.5 Kite Pharma
5.5.1 Kite Pharma Profile
5.5.2 Kite Pharma Main Business
5.5.3 Kite Pharma Immune Cell Therapy Products, Services and Solutions
5.5.4 Kite Pharma Immune Cell Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Kite Pharma Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Immune Cell Therapy Products, Services and Solutions
5.6.4 Novartis Immune Cell Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis Recent Developments
5.7 Takara Bio
5.7.1 Takara Bio Profile
5.7.2 Takara Bio Main Business
5.7.3 Takara Bio Immune Cell Therapy Products, Services and Solutions
5.7.4 Takara Bio Immune Cell Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Takara Bio Recent Developments
5.8 Unum Therapeutics
5.8.1 Unum Therapeutics Profile
5.8.2 Unum Therapeutics Main Business
5.8.3 Unum Therapeutics Immune Cell Therapy Products, Services and Solutions
5.8.4 Unum Therapeutics Immune Cell Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Unum Therapeutics Recent Developments
6 North America
6.1 North America Immune Cell Therapy Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immune Cell Therapy Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immune Cell Therapy Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immune Cell Therapy Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immune Cell Therapy Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immune Cell Therapy Market Dynamics
11.1 Immune Cell Therapy Industry Trends
11.2 Immune Cell Therapy Market Drivers
11.3 Immune Cell Therapy Market Challenges
11.4 Immune Cell Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Immune Cell Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2023 VS 2033
Table 2. Global Immune Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Immune Cell Therapy Market Size Share by Region (2018-2023)
Table 4. Global Immune Cell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Immune Cell Therapy Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Immune Cell Therapy Market Size (US$ Million) by Type: 2018 VS 2023 VS 2033
Table 7. Global Immune Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Immune Cell Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global Immune Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Immune Cell Therapy Revenue Market Share by Type (2024-2033)
Table 11. North America Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Immune Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Immune Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Immune Cell Therapy Market Size (US$ Million) by Application: 2018 VS 2023 VS 2033
Table 22. Global Immune Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Immune Cell Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global Immune Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Immune Cell Therapy Revenue Market Share by Application (2024-2033)
Table 26. North America Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Immune Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Immune Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Immune Cell Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Immune Cell Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Cell Therapy as of 2023)
Table 39. Date of Key Players Enter into Immune Cell Therapy Market
Table 40. Global Immune Cell Therapy Key Players Headquarters and Area Served
Table 41. Immune Cell Therapy Product Solution and Service
Table 42. Global Immune Cell Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Adaptimmune Basic Information List
Table 45. Adaptimmune Description and Business Overview
Table 46. Adaptimmune Immune Cell Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Immune Cell Therapy Business of Adaptimmune (2018-2023)
Table 48. Adaptimmune Recent Developments
Table 49. Altor Bioscience Corporation Basic Information List
Table 50. Altor Bioscience Corporation Description and Business Overview
Table 51. Altor Bioscience Corporation Immune Cell Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Immune Cell Therapy Business of Altor Bioscience Corporation (2018-2023)
Table 53. Altor Bioscience Corporation Recent Developments
Table 54. Cellectis Basic Information List
Table 55. Cellectis Description and Business Overview
Table 56. Cellectis Immune Cell Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Immune Cell Therapy Business of Cellectis (2018-2023)
Table 58. Cellectis Recent Developments
Table 59. Juno Therapeutics Basic Information List
Table 60. Juno Therapeutics Description and Business Overview
Table 61. Juno Therapeutics Immune Cell Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Immune Cell Therapy Business of Juno Therapeutics (2018-2023)
Table 63. Juno Therapeutics Recent Developments
Table 64. Kite Pharma Basic Information List
Table 65. Kite Pharma Description and Business Overview
Table 66. Kite Pharma Immune Cell Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Immune Cell Therapy Business of Kite Pharma (2018-2023)
Table 68. Kite Pharma Recent Developments
Table 69. Novartis Basic Information List
Table 70. Novartis Description and Business Overview
Table 71. Novartis Immune Cell Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Immune Cell Therapy Business of Novartis (2018-2023)
Table 73. Novartis Recent Developments
Table 74. Takara Bio Basic Information List
Table 75. Takara Bio Description and Business Overview
Table 76. Takara Bio Immune Cell Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Immune Cell Therapy Business of Takara Bio (2018-2023)
Table 78. Takara Bio Recent Developments
Table 79. Unum Therapeutics Basic Information List
Table 80. Unum Therapeutics Description and Business Overview
Table 81. Unum Therapeutics Immune Cell Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Immune Cell Therapy Business of Unum Therapeutics (2018-2023)
Table 83. Unum Therapeutics Recent Developments
Table 84. North America Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 85. North America Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 86. Europe Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 87. Europe Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 88. Asia-Pacific Immune Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 89. Asia-Pacific Immune Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific Immune Cell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 91. Asia-Pacific Immune Cell Therapy Market Share by Region (2018-2023)
Table 92. Asia-Pacific Immune Cell Therapy Market Share by Region (2024-2033)
Table 93. Latin America Immune Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 94. Latin America Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 95. Latin America Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 96. Middle East & Africa Immune Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 97. Middle East & Africa Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 98. Middle East & Africa Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 99. Immune Cell Therapy Market Trends
Table 100. Immune Cell Therapy Market Drivers
Table 101. Immune Cell Therapy Market Challenges
Table 102. Immune Cell Therapy Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Cell Therapy Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Immune Cell Therapy Market Size (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Immune Cell Therapy Market Share by Regions: 2023 VS 2033
Figure 4. Global Immune Cell Therapy Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Immune Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Immune Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Immune Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Immune Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Immune Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of T Cell Therapy
Figure 11. Global T Cell Therapy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Natural Killer (NK) Cell Therapy
Figure 13. Global Natural Killer (NK) Cell Therapy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Other
Figure 15. Global Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Global Immune Cell Therapy Market Size Share by Type: 2023 & 2033
Figure 17. North America Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 18. Europe Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 19. Asia-Pacific Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 20. Latin America Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 21. Middle East and Africa Immune Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 22. Stomach Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Lung Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Esophageal Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Pancreatic Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Global Immune Cell Therapy Market Size Share by Application: 2023 & 2033
Figure 29. North America Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 30. Europe Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 31. Asia-Pacific Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 32. Latin America Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 33. Middle East and Africa Immune Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 34. Immune Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2023
Figure 35. Global Top 5 and Top 10 Players Immune Cell Therapy Market Share in 2023
Figure 36. North America Immune Cell Therapy Market Share by Country (2018-2033)
Figure 37. U.S. Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 38. Canada Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 39. Germany Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 40. France Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 41. U.K. Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 42. Italy Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 43. Russia Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 44. Nordic Countries Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 45. Asia-Pacific Immune Cell Therapy Market Share by Region (2018-2033)
Figure 46. China Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 47. Japan Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 48. South Korea Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 49. Southeast Asia Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 50. India Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 51. Australia Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 52. Latin America Immune Cell Therapy Market Share by Country (2018-2033)
Figure 53. Mexico Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 54. Brazil Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 55. Middle East & Africa Immune Cell Therapy Market Share by Country (2018-2033)
Figure 56. Turkey Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 58. UAE Immune Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries